HPLC-MS/MS法测定人血浆中普罗布考浓度
Determination of Probucol in Human Plasma by HPLC-MS/MS
-
摘要: 目的 建立高效液相色谱-串联质谱(HPLC-MS/MS)技术测定人血浆中普罗布考浓度的方法。 方法 血浆经乙酸乙酯:二氯甲烷(1:1,V/V)提取后,采用HPLC-MS/MS测定。以ultimate CN(50 mm×4.6 mm,5 μm)为色谱柱,乙腈:水:氨水=97:3:0.05(甲酸调pH=7.20)为流动相进行分离。质谱采用负离子模式检测,以大黄素甲醚为内标,检测离子515.5→236.1(普罗布考)和283.0→239.9(内标)。 结果 普罗布考在2.5~6000 ng/mL范围内线性关系良好,最低定量限为2.5 ng/mL,方法回收率在93.02%~104.12%之间,日内、日间精密度分别小于4.67%及5.72%。 结论 本研究所建立的方法准确、灵敏,可用于普罗布考血药浓度测定及药代动力学研究。Abstract: Objective To develop a specific and sensitive method for the determination of probucol in human plasma using HPLC-MS/MS technique. Methods Probucol were extracted from plasma by ethyl ether:dichloromethane (1:1, V/V), with physcion as an internal standard. The analytes went through the column of ultimate CN (50 mm×4.6 mm, 5 μm) with mobile phase acetonitrile:water:ammonia water=97:3:0.05 (adjusted pH=7.2 with formic acid). Probucol was analyzed with a negative mode. The ion pairs being detected were 515.5→236.1 (probucol) and 283.0→239.9 physcion, respectively. Results The established method was able to determine probucol in human plasma over the range of 2.5-6000 ng/mL, with a method recovery ranging from 93.02% to 104.12%. The intra and inter day variances were below 4.67% and 5.72%. Conclusion The HPLC-MS/MS method for analyzing probucol was validated. It is sensitive and suitable for pharmacokinetic studies of probucol.
© 2012 《koko体育app
学报(医学版)》编辑部 版权所有
开放获取🎃 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问